Ultrathin Bronchoscopy for Solitary Pulmonary Nodules (Babyscope)
Lung Cancer
About this trial
This is an interventional diagnostic trial for Lung Cancer
Eligibility Criteria
Inclusion Criteria:
- Pulmonary nodule on a recent CT
- non-visible on standard-size bronchoscopy
Exclusion Criteria:
- missing informed consent
Sites / Locations
- University Hospital Zurich
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Standard size bronchoscopy
Ultrahin bronchoscopy
ll procedures were started using SB with an external diameter of 5.0-6.0 mm with a biopsy channel of 2.2-2.8 mm (models Olympus BF-30 and BF-1T160, Olympus, Tokyo, Japan). If during SB the lesion was endoscopically visible the bronchoscopy was continued as standard diagnostic procedure and the patients were excluded from the analysis. Only if no tumour was visible during complete inspection of the bronchial tree using the SB, a participant was randomised by opening a numbered sealed opaque envelope. Randomisation was performed using sequentially numbered (1-40) sealed opaque envelopes (block randomisation: block size 4). For subjects allocated to the SB group, the examination was immediately continued with the same SB bronchoscope.
For subjects randomised to UB, the instrument was changed immediately to an Olympus BF-XP 40 ultrathin bronchoscope with an outer diameter of 2.8 mm and a working channel 1.2 mm during the same bronchoscopy session.